LIMITATION OF MYOCARDIAL INFARCT SIZE BY ATENOLOL, NADOLOL AND PROPRANOLOL IN DOGS

被引:27
作者
BURMEISTER, WE [1 ]
REYNOLDS, RD [1 ]
LEE, RJ [1 ]
机构
[1] AMER CRIT CARE,DEPT PHARMACEUT RES,MCGAW PK,IL 60085
关键词
D O I
10.1016/0014-2999(81)90338-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:7 / 10
页数:4
相关论文
共 14 条
[1]   A COMPARISON OF EFFECTS OF (+-)-PROPRANOLOL AND (+)-PROPRANOLOL IN ANAESTHETIZED DOGS - BETA-RECEPTOR BLOCKING AND HAEMODYNAMIC ACTION [J].
BARRETT, AM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (04) :241-&
[2]  
BARRETT AM, 1973, BRIT J PHARMACOL, V48, P340
[3]  
BURMEISTER WE, 1979, FED PROC, V38, P694
[4]   HEMODYNAMIC EFFECTS OF (+/-)-PROPRANOLOL, DEXPROPRANOLOL, OXPRENOLOL, PRACTOLOL AND SOTALOL IN ANESTHETIZED DOGS [J].
FITZ GERALD, JD ;
WALE, JL ;
AUSTIN, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 17 (01) :123-+
[5]  
JESMOK JG, 1978, AM J CARDIOL, V42, P796
[6]   PHARMACOLOGY OF NADOLOL (SQ 11725), A BETA-ADRENERGIC ANTAGONIST LACKING DIRECT MYOCARDIAL DEPRESSION [J].
LEE, RJ ;
EVANS, DB ;
BAKY, SH ;
LAFFAN, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (02) :371-382
[7]  
LUCCHESI BR, 1976, J PHARMACOL EXP THER, V199, P310
[8]   EFFECT OF DELAY IN PROPRANOLOL ADMINISTRATION ON REDUCTION OF MYOCARDIAL INFARCT SIZE AFTER EXPERIMENTAL CORONARY-ARTERY OCCLUSION IN DOGS [J].
MIURA, M ;
THOMAS, R ;
GANZ, W ;
SOKOL, T ;
SHELL, WE ;
TOSHIMITSU, T ;
KWAN, AC ;
SINGH, BN .
CIRCULATION, 1979, 59 (06) :1148-1157
[9]  
NACHLAS MM, 1963, AM J PATHOL, V42, P379
[10]   FAILURE OF HIGH DOSES OF PROPRANOLOL TO REDUCE EXPERIMENTAL MYOCARDIAL ISCHEMIC DAMAGE [J].
PETER, T ;
HENG, MK ;
SINGH, BN ;
AMBLER, P ;
NISBET, H ;
ELLIOT, R ;
NORRIS, RM .
CIRCULATION, 1978, 57 (03) :534-540